In 2018, Bayer acquired the US agrochemical and agricultural chemicals company Monsanto. However, the deal, valued at around USD 64 billion, raised a number of questions. As a result of the merger, Bayer has since found itself responsible for a number of controversial practices of the US company. This is associated not only with sustainability risks but also with a potential risk of billions through various class actions.
![A Tale of Two Companies: Bayer’s Biodiversity Conundrum with Monsanto A Tale of Two Companies: Bayer’s Biodiversity Conundrum with Monsanto](https://blog.en.erste-am.com/wp-content/uploads/2023/07/05_TITELBILD_Varga_c_Ohde_Christian_Action_Press_picturedesk.com_-scaled-370x210-1690273116.jpg)